Helixgate

Helixgate

Uncategorized

STAT+: Influential Democratic think tank pushes plan for government to lower health care costs

Published

on

WASHINGTON — An influential progressive think tank is proposing that Democrats assert more federal government control over hospitals and private insurers to make health care more affordable.

Democrats have set out to gather ideas for overhauling the health care system in preparation for potentially regaining control of the government. Democrats see themselves in a “blue sky moment” following Republicans’ big cuts to health care funding, and they want to give themselves plenty of time to devise a fresh approach so they’re ready to strike if and when they get the chance.

The latest blueprint comes from the Center for American Progress, first reported by The Bulwark.

Continue to STAT+ to read the full story…

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Uncategorized

From Product to Patient in Nuclear Medicine: Why Vertical Integration Is Essential for a Competitive Advantage

From Product to Patient in Nuclear Medicine: Why Vertical Integration Is Essential for a Competitive Advantage

Published

on

In nuclear medicine, innovation alone isn’t enough. What matters is whether it can be delivered on time, every time, because timing is critical for our patients. And that delivery promise must hold up under real-world pressure – from routine variability to sudden disruptions that can reroute global logistics overnight.​ ​Read More

Continue Reading

Uncategorized

KRAS drugmakers take another, better swing at lung cancer

Published

on

SAN DIEGO — In early cuts of data, the next iteration of KRAS drugs for lung cancer appears to bear more promise than the first.

KRAS mutations drive around a quarter of all cancer cases and …

Continue Reading

Uncategorized

UCB plots epilepsy expansion with $650M Neurona cell therapy acquisition

Published

on

UCB plans to pay $650 million to Neurona Therapeutics in a bid to broaden its clinical-stage epilepsy portfolio.

The deal comes with as much as $500 million in milestone payments.

Neurona is developing a treatment …

Continue Reading
Advertisement

Trending